Mechanisms of risk in preterm low-birthweight infants

C E Williams1, E S Davenport, J A Sterne

  • 1Department of Paediatric Dentistry, St Bartholomew's and the Royal London Hospital, London, England, United Kingdom.

Periodontology 2000
|March 30, 2001
PubMed

Insights

Periodontal diseases share risk factors with preterm low birth weight infants. While not causal, inflammatory mediators link these conditions, prompting further research into contributing factors and probabilities.

Area of Science:

  • Oral health
  • Maternal-fetal medicine
  • Public health

Background:

  • Periodontal diseases and preterm low birth weight share common risk factors such as age, socioeconomic status, and smoking.
  • Current research indicates an association, not a causal link, between periodontal diseases and preterm low birth weight.
  • Inflammatory mediators involved in periodontal diseases may play a role in initiating labor.

Purpose of the Study:

  • To investigate the association between periodontal diseases and preterm low birth weight.
  • To explore potential biological mechanisms linking these conditions.
  • To identify and characterize risk factors for preterm low birth weight.

Main Methods:

  • Review of existing studies on risk factors for periodontal diseases and preterm low birth weight.
  • Analysis of inflammatory mediators involved in periodontal disease and labor initiation.
  • Ongoing global studies to determine probabilities and causal relationships.

Main Results:

  • Established association between periodontal diseases and preterm low birth weight, with shared risk factors identified.
  • Plausible biological mechanisms involving inflammatory mediators suggest a potential link.
  • Further research is needed to establish causality and quantify risk.

Conclusions:

  • Periodontal diseases and preterm low birth weight share risk factors and plausible biological mechanisms.
  • Future research should focus on characterizing predisposing factors and their probabilities.
  • Intervention studies and detailed mechanistic examinations are crucial for understanding maternal infection effects.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...